Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Assesment of Risk Factors for Tardive Dyskinesia (OPEN ACCESS)
1
x
$
0.00
New Developments in the Neurobiological Basis of Anxiety Disorders
1
x
$
30.00
Psychologically Traumatic Oxidative Stress; A Comprehensive Review of Redox Mechanisms and Related Inflammatory Implications
1
x
$
30.00
Letter From the Editors: Are We Prepared for the Genomics Era?
1
x
$
0.00
Hyperprolactinemia, Clinical Considerations, and Infertility in Women on Antipsychotic Medications
1
x
$
30.00
Probable Risperidone-Associated Acute Pancreatitis in a Child with ADHD
1
x
$
30.00
Do Long-Acting Injectable Antipsychotics Prevent or Delay Hospital Readmission?
1
x
$
30.00
Letter From the Editors: Addressing the Quality Chasm for a New Health System in the 21st Century
1
x
$
0.00
Treatment of Insomnia with Zaleplon in HIV+ Significantly Improves Sleep and Depression
1
x
$
30.00
Epidemiología psiquiátrica: Psiquiatría social versus epidemiología
1
x
$
0.00
Brexpiprazole for the Treatment of Schizophrenia and Major Depressive Disorder: A Comprehensive Review of Pharmacological Considerations in Clinical Practice
1
x
$
30.00
View Cart
Checkout
Home
Store
“Brexpiprazole for the Treatment of Schizophrenia and Major Depressive Disorder: A Comprehensive Review of Pharmacological Considerations in Clinical Practice” has been added to your cart.
View cart
Sort by
Popularity
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Successful Management of Psychotropics Induced Stuttering Priapism with Pseudoephedrine in a Patient with Schizophrenia
$
30.00
Add to cart
Details
John P. Houston – Early Symptom Change Prediction of Remission in Depression Treatment
$
30.00
Add to cart
Details
A Case of Clozapine Induced Mania-Like Symptoms in the Treatment of Schizophrenia
$
30.00
Add to cart
Details
A Bell’s Palsy Case Probably Related to Sertraline Use
$
30.00
Add to cart
Details
The Prescriber’s Guide to the MAOI Diet—Thinking Through Tyramine Troubles
$
30.00
Add to cart
Details
Paroxetine versus Vortioxetine for Depressive Symptoms in Postmenopausal Transition: A Preliminary Study
$
30.00
Add to cart
Details
Psychopharmacology Bulletin VOL 46 No. 1 – Full Issue Stacked PDF
$
60.00
Add to cart
Details
A Systematic Review of Augmentation Strategies for Major Depressive Disorder
$
30.00
Add to cart
Details
The Black Book of Psychotropic Dosing and Monitoring
$
30.00
Add to cart
Details
Adjunctive Pimavanserin in Patients with Major Depressive Disorder: Combined Results from Two Randomized, Double-Blind, Placebo-Controlled Phase 3 Studies
$
30.00
Add to cart
Details
Lumateperone for the Treatment of Schizophrenia
$
30.00
Add to cart
Details
Paroxetine—The Antidepressant from Hell? Probably Not, But Caution Required
$
30.00
Add to cart
Details
A Placebo-Controlled Trial of Guanfacine for the Treatment of Posttraumatic Stress Disorder in Veterans
$
30.00
Add to cart
Details
Successful Add-on Viloxazine to Clozapine-Responsive Schizophrenia Mitigated Cognitive, Negative and Metabolic Domains
$
30.00
Add to cart
Details
Sequential Multiple Assignment Randomized Treatment (SMART) for Bipolar Disorder at Any Phase of Illness and at least Mild Symptom Severity
$
30.00
Add to cart
Details
Psychopharmacology Bulletin VOL 37 Supplement No. 2 – Full Issue Stacked PDF
$
60.00
Add to cart
Details
A Failed 6-Week, Randomized, Double-Blind, Placebo-Controlled Study of Once-Daily Extended Release Quetiapine Fumarate in Patients with Acute Schizophrenia: Lessons Learned
$
30.00
Add to cart
Details
Raised Creatine Kinase with Numerous Antipsychotics Responded to Clozapine
$
30.00
Add to cart
Details
Early Positive Report of Viloxazine for a Child with Hyperkinetic Autism
$
30.00
Add to cart
Details
Pregabalin Adjuventia Helped Risperidone-Induced Extrapyramidal Syndrome and Augmented Antipsychotic Response in an Adolescent with Schizophrenia
$
30.00
Add to cart
Details
Previous
1
2
3
4
…
44
Next
Page load link
Go to Top
